245 related articles for article (PubMed ID: 37619559)
1. A proteogenomics data-driven knowledge base of human cancer.
Liao Y; Savage SR; Dou Y; Shi Z; Yi X; Jiang W; Lei JT; Zhang B
Cell Syst; 2023 Sep; 14(9):777-787.e5. PubMed ID: 37619559
[TBL] [Abstract][Full Text] [Related]
2. Proteogenomic data and resources for pan-cancer analysis.
Li Y; Dou Y; Da Veiga Leprevost F; Geffen Y; Calinawan AP; Aguet F; Akiyama Y; Anand S; Birger C; Cao S; Chaudhary R; Chilappagari P; Cieslik M; Colaprico A; Zhou DC; Day C; Domagalski MJ; Esai Selvan M; Fenyö D; Foltz SM; Francis A; Gonzalez-Robles T; Gümüş ZH; Heiman D; Holck M; Hong R; Hu Y; Jaehnig EJ; Ji J; Jiang W; Katsnelson L; Ketchum KA; Klein RJ; Lei JT; Liang WW; Liao Y; Lindgren CM; Ma W; Ma L; MacCoss MJ; Martins Rodrigues F; McKerrow W; Nguyen N; Oldroyd R; Pilozzi A; Pugliese P; Reva B; Rudnick P; Ruggles KV; Rykunov D; Savage SR; Schnaubelt M; Schraink T; Shi Z; Singhal D; Song X; Storrs E; Terekhanova NV; Thangudu RR; Thiagarajan M; Wang LB; Wang JM; Wang Y; Wen B; Wu Y; Wyczalkowski MA; Xin Y; Yao L; Yi X; Zhang H; Zhang Q; Zuhl M; Getz G; Ding L; Nesvizhskii AI; Wang P; Robles AI; Zhang B; Payne SH;
Cancer Cell; 2023 Aug; 41(8):1397-1406. PubMed ID: 37582339
[TBL] [Abstract][Full Text] [Related]
3. A User-Friendly Visualization Tool for Multi-Omics Data.
Huh S; Kim MS
Proteomics; 2020 Nov; 20(21-22):e2000136. PubMed ID: 32744797
[TBL] [Abstract][Full Text] [Related]
4. Integration and Analysis of CPTAC Proteomics Data in the Context of Cancer Genomics in the cBioPortal.
Wu P; Heins ZJ; Muller JT; Katsnelson L; de Bruijn I; Abeshouse AA; Schultz N; Fenyö D; Gao J
Mol Cell Proteomics; 2019 Sep; 18(9):1893-1898. PubMed ID: 31308250
[TBL] [Abstract][Full Text] [Related]
5. Simplified and Unified Access to Cancer Proteogenomic Data.
Lindgren CM; Adams DW; Kimball B; Boekweg H; Tayler S; Pugh SL; Payne SH
J Proteome Res; 2021 Apr; 20(4):1902-1910. PubMed ID: 33560848
[TBL] [Abstract][Full Text] [Related]
6. The CPTAC Data Portal: A Resource for Cancer Proteomics Research.
Edwards NJ; Oberti M; Thangudu RR; Cai S; McGarvey PB; Jacob S; Madhavan S; Ketchum KA
J Proteome Res; 2015 Jun; 14(6):2707-13. PubMed ID: 25873244
[TBL] [Abstract][Full Text] [Related]
7. Mass Spectrometry-Based Proteogenomics: New Therapeutic Opportunities for Precision Medicine.
Joshi SK; Piehowski P; Liu T; Gosline SJC; McDermott JE; Druker BJ; Traer E; Tyner JW; Agarwal A; Tognon CE; Rodland KD
Annu Rev Pharmacol Toxicol; 2024 Jan; 64():455-479. PubMed ID: 37738504
[TBL] [Abstract][Full Text] [Related]
8. Community Assessment of the Predictability of Cancer Protein and Phosphoprotein Levels from Genomics and Transcriptomics.
Yang M; Petralia F; Li Z; Li H; Ma W; Song X; Kim S; Lee H; Yu H; Lee B; Bae S; Heo E; Kaczmarczyk J; Stępniak P; Warchoł M; Yu T; Calinawan AP; Boutros PC; Payne SH; Reva B; ; Boja E; Rodriguez H; Stolovitzky G; Guan Y; Kang J; Wang P; Fenyö D; Saez-Rodriguez J
Cell Syst; 2020 Aug; 11(2):186-195.e9. PubMed ID: 32710834
[TBL] [Abstract][Full Text] [Related]
9. Current Challenges and Implications of Proteogenomic Approaches in Prostate Cancer.
Shukla N; Siva N; Malik B; Suravajhala P
Curr Top Med Chem; 2020; 20(22):1968-1980. PubMed ID: 32703135
[TBL] [Abstract][Full Text] [Related]
10. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.
Gillette MA; Satpathy S; Cao S; Dhanasekaran SM; Vasaikar SV; Krug K; Petralia F; Li Y; Liang WW; Reva B; Krek A; Ji J; Song X; Liu W; Hong R; Yao L; Blumenberg L; Savage SR; Wendl MC; Wen B; Li K; Tang LC; MacMullan MA; Avanessian SC; Kane MH; Newton CJ; Cornwell M; Kothadia RB; Ma W; Yoo S; Mannan R; Vats P; Kumar-Sinha C; Kawaler EA; Omelchenko T; Colaprico A; Geffen Y; Maruvka YE; da Veiga Leprevost F; Wiznerowicz M; Gümüş ZH; Veluswamy RR; Hostetter G; Heiman DI; Wyczalkowski MA; Hiltke T; Mesri M; Kinsinger CR; Boja ES; Omenn GS; Chinnaiyan AM; Rodriguez H; Li QK; Jewell SD; Thiagarajan M; Getz G; Zhang B; Fenyö D; Ruggles KV; Cieslik MP; Robles AI; Clauser KR; Govindan R; Wang P; Nesvizhskii AI; Ding L; Mani DR; Carr SA;
Cell; 2020 Jul; 182(1):200-225.e35. PubMed ID: 32649874
[TBL] [Abstract][Full Text] [Related]
11. ProTrack: An Interactive Multi-Omics Data Browser for Proteogenomic Studies.
Calinawan AP; Song X; Ji J; Dhanasekaran SM; Petralia F; Wang P; Reva B
Proteomics; 2020 Nov; 20(21-22):e1900359. PubMed ID: 32510176
[TBL] [Abstract][Full Text] [Related]
12. Cancer proteogenomics: current impact and future prospects.
Mani DR; Krug K; Zhang B; Satpathy S; Clauser KR; Ding L; Ellis M; Gillette MA; Carr SA
Nat Rev Cancer; 2022 May; 22(5):298-313. PubMed ID: 35236940
[TBL] [Abstract][Full Text] [Related]
13. Pan-cancer proteogenomics characterization of tumor immunity.
Petralia F; Ma W; Yaron TM; Caruso FP; Tignor N; Wang JM; Charytonowicz D; Johnson JL; Huntsman EM; Marino GB; Calinawan A; Evangelista JE; Selvan ME; Chowdhury S; Rykunov D; Krek A; Song X; Turhan B; Christianson KE; Lewis DA; Deng EZ; Clarke DJB; Whiteaker JR; Kennedy JJ; Zhao L; Segura RL; Batra H; Raso MG; Parra ER; Soundararajan R; Tang X; Li Y; Yi X; Satpathy S; Wang Y; Wiznerowicz M; González-Robles TJ; Iavarone A; Gosline SJC; Reva B; Robles AI; Nesvizhskii AI; Mani DR; Gillette MA; Klein RJ; Cieslik M; Zhang B; Paulovich AG; Sebra R; Gümüş ZH; Hostetter G; Fenyö D; Omenn GS; Cantley LC; Ma'ayan A; Lazar AJ; Ceccarelli M; Wang P;
Cell; 2024 Feb; 187(5):1255-1277.e27. PubMed ID: 38359819
[TBL] [Abstract][Full Text] [Related]
14. Pan-cancer proteogenomics connects oncogenic drivers to functional states.
Li Y; Porta-Pardo E; Tokheim C; Bailey MH; Yaron TM; Stathias V; Geffen Y; Imbach KJ; Cao S; Anand S; Akiyama Y; Liu W; Wyczalkowski MA; Song Y; Storrs EP; Wendl MC; Zhang W; Sibai M; Ruiz-Serra V; Liang WW; Terekhanova NV; Rodrigues FM; Clauser KR; Heiman DI; Zhang Q; Aguet F; Calinawan AP; Dhanasekaran SM; Birger C; Satpathy S; Zhou DC; Wang LB; Baral J; Johnson JL; Huntsman EM; Pugliese P; Colaprico A; Iavarone A; Chheda MG; Ricketts CJ; Fenyö D; Payne SH; Rodriguez H; Robles AI; Gillette MA; Kumar-Sinha C; Lazar AJ; Cantley LC; Getz G; Ding L;
Cell; 2023 Aug; 186(18):3921-3944.e25. PubMed ID: 37582357
[TBL] [Abstract][Full Text] [Related]
15. Proteogenomics: Key Driver for Clinical Discovery and Personalized Medicine.
Barbieri R; Guryev V; Brandsma CA; Suits F; Bischoff R; Horvatovich P
Adv Exp Med Biol; 2016; 926():21-47. PubMed ID: 27686804
[TBL] [Abstract][Full Text] [Related]
16. The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment.
Rodriguez H; Zenklusen JC; Staudt LM; Doroshow JH; Lowy DR
Cell; 2021 Apr; 184(7):1661-1670. PubMed ID: 33798439
[TBL] [Abstract][Full Text] [Related]
17. Clinical potential of mass spectrometry-based proteogenomics.
Zhang B; Whiteaker JR; Hoofnagle AN; Baird GS; Rodland KD; Paulovich AG
Nat Rev Clin Oncol; 2019 Apr; 16(4):256-268. PubMed ID: 30487530
[TBL] [Abstract][Full Text] [Related]
18. Proteogenomic interrogation of cancer cell lines: an overview of the field.
Tsang O; Wong JWH
Expert Rev Proteomics; 2021 Mar; 18(3):221-232. PubMed ID: 33877947
[No Abstract] [Full Text] [Related]
19. Frontiers in mass spectrometry-based clinical proteomics for cancer diagnosis and treatment.
Haga Y; Minegishi Y; Ueda K
Cancer Sci; 2023 May; 114(5):1783-1791. PubMed ID: 36661476
[TBL] [Abstract][Full Text] [Related]
20. Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities.
Vasaikar S; Huang C; Wang X; Petyuk VA; Savage SR; Wen B; Dou Y; Zhang Y; Shi Z; Arshad OA; Gritsenko MA; Zimmerman LJ; McDermott JE; Clauss TR; Moore RJ; Zhao R; Monroe ME; Wang YT; Chambers MC; Slebos RJC; Lau KS; Mo Q; Ding L; Ellis M; Thiagarajan M; Kinsinger CR; Rodriguez H; Smith RD; Rodland KD; Liebler DC; Liu T; Zhang B;
Cell; 2019 May; 177(4):1035-1049.e19. PubMed ID: 31031003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
